Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).
about
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Chemotherapy vs tamoxifen in p ...... multicentre trial (Ovaresist).
@en
Chemotherapy vs tamoxifen in p ...... multicentre trial (Ovaresist).
@nl
type
label
Chemotherapy vs tamoxifen in p ...... multicentre trial (Ovaresist).
@en
Chemotherapy vs tamoxifen in p ...... multicentre trial (Ovaresist).
@nl
prefLabel
Chemotherapy vs tamoxifen in p ...... multicentre trial (Ovaresist).
@en
Chemotherapy vs tamoxifen in p ...... multicentre trial (Ovaresist).
@nl
P2093
P2860
P921
P356
P1476
Chemotherapy vs tamoxifen in p ...... multicentre trial (Ovaresist)
@en
P2093
Elisabet Hjerpe
Elisabeth Åvall-Lundqvist
Emma Gibbs
Gunnar Kristensen
Kathrine Woie
Kristina Lindemann
Marten Kalling
Per Rosenberg
Rene dePont Christensen
Seija Grenman
P2860
P2888
P304
P356
10.1038/BJC.2016.435
P407
P577
2017-01-24T00:00:00Z